Cristin-person-ID: 37026
Person

Karin Inger Martina Fahl Wader

  • Stilling:
    Førsteamanuensis
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet
  • Stilling:
    Overlege onkologi
    ved Kreftklinikken ved St. Olavs Hospital HF

Resultater Resultater

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.

Jerkeman, Mats; Kolstad, Arne; Hutchings, Martin; Pasanen, Annika; Meriranta, Leo; Niemann, Carsten Utoft; Jørgensen, Rasmus Rask Kragh; El-Galaly, Tarec Christoffer; Riise, Jon; Leppä, Sirpa mfl.. 2024, Blood Advances. Uu, KAROLINSKA, OUH, Lu, OUS, INNLANDET, SUS, STOLAV, AAU, RH, HYKS, KI, AARHUSSYKEVitenskapelig artikkel

Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

Riise, Jon; Meyer, Saskia; Blaas, Isaac; Chopra, Adity; Tran, Trung; Delic-Sarac, Marina; Hestdalen, Malu Lian; Brodin, Ellen Elisabeth; Rustad, Even Holth; Dai, Ke-Zheng mfl.. 2022, British Journal of Haematology. SUS, STOLAV, UNN, HAUKELAND, UIO, AHUS, OUSVitenskapelig artikkel

Reply to M. Sorigue et al.

Lockmer, Sandra; Østenstad, Bjørn; Hagberg, Hans; Holte, Harald; Wahlin, Björn Engelbrekt; Wader, Karin Fahl; Smedby, Karin E.; Brown, Peter; Kimby, Eva. 2019, Journal of Clinical Oncology. AKADEMISKA, KAROLINSKA, STOLAV, RH, OUS, KIBrev til redaktøren

Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: Results from two Nordic lymphoma group trials with more than 10 years of follow-up.

Lockmer, Sandra; Østenstad, Bjørn; Hagberg, Hans; Holte, Harald; Johansson, Ann-Sofie; Wahlin, Björn Engelbrekt; Wader, Karin Fahl; Steen, Chloe Beate; Meyer, Peter Albert; Maisenhölder, Martin mfl.. 2018, Journal of Clinical Oncology. SUS, KAROLINSKA, AKADEMISKA, UNN, STOLAV, RH, UIO, OUS, NUS, KIVitenskapelig artikkel

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial.

Jerkeman, Mats; Eskelund, Christian Winther; Hutchings, Martin; Räty, Riikka; Wader, Karin Fahl; Laurell, Anna; Toldbod, Helle; Pedersen, Lone Bredo; Niemann, Carsten Utoft; Dahl, Christina mfl.. 2018, The Lancet Haematology. AKADEMISKA, STOLAV, RH, OYS, Lu, KU, HYKS, OUS, CANCER, AARHUSSYKEVitenskapelig artikkel
1 - 5 av 25 | Neste | Siste »